Search

Displaying results 4591 - 4600 of 7602 in total
  1. Drug

    RTX-117

    go.drugbank.com/drugs/DB28443
    Experimental

    RTX-117 is being investigated for Charcot-Marie-Tooth disease (CMT).[L54166]

  2. Drug

    Lobeglitazone

    go.drugbank.com/drugs/DB09198
    Investigational

    Lobeglitazone is not approved for use by either the Food and Drug Administration (USA), Health Canada, or by the European Medicines Agency for use in the management of diabetes.

  3. Drug

    Polaprezinc

    go.drugbank.com/drugs/DB09221
    Investigational

    Polaprezinc is a chelated form of zinc and L-carnosine. It is a zinc-related medicine approved for the first time in Japan, which has been clinically used to treat gastric ulcers [L1307, L1308].

  4. Drug

    ZKN-013

    go.drugbank.com/drugs/DB32582
    Experimental

    ZKN-013 is a readthrough inducer under investigation for rare dermatological diseases.[L56075]

  5. Drug

    Vixotrigine

    go.drugbank.com/drugs/DB11706
    Investigational

    Vixotrigine has been investigated for the treatment of Bipolar Disorder and Bipolar Depression.

  6. Drug

    VO659

    go.drugbank.com/drugs/DB18160
    Investigational

    VO659 is an antisense oligonucleotide being investigated for the treatment of Huntington's disease.

  7. Drug

    VG161

    go.drugbank.com/drugs/DB18469
    Investigational

    VG161 is an oncolytic virus therapy under investigation for the treatment of cholangiocarcinoma.

  8. Drug

    Pristimerin

    go.drugbank.com/drugs/DB17049
    Experimental

    Pristimerin is a quinone methide triterpenoid researched for its anti-cancer potential.[A253107]

  9. Drug

    Picropodophyllin

    go.drugbank.com/drugs/DB12802
    Investigational

    Picropodophyllin has been investigated for the treatment of Non Small Cell Lung Cancer.

  10. Drug

    Pancreatic Polypeptide

    go.drugbank.com/drugs/DB12822
    Investigational

    Pancreatic Polypeptide has been investigated for the treatment of Diabetes Mellitus, Type 1.